Heterogeneity index evaluated by slope of linear regression on 18F-FDG PET/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Yong-il Kim
Yong Joong Kim
Jin Chul Paeng
Gi Jeong Cheon
Dong Soo Lee
June-Key Chung
Keon Wook Kang
机构：
[1] CHA University,Department of Nuclear Medicine, CHA Bundang Medical Center
[2] Seoul National University Hospital,Department of Nuclear Medicine
[3] Veterans Health Service Medical Center,Cancer Research Institute
[4] Seoul National University,Department of Biomedical Sciences
[5] Seoul National University College of Medicine,Department of Nuclear Medicine
[6] Seoul National University College of Medicine,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2017年 / 44卷
关键词：
Pancreatic cancer; Recurrence; Heterogeneity; Metabolic tumor volume; Total lesion glycolysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1995 / 2003
页数：8
相关论文
共 50 条
  • [21] The role of 18F-FDG PET/CT predicting microvascular tumor invasion in patients with hepatocellular carcinoma
    Aktas, Hikmet
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2020, 11 : 20 - 22
  • [22] Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer
    Vadi, Shelvin K.
    Mittal, Bhagwant R.
    Sood, Ashwani
    Singh, Gurpreet
    Bal, Amanjit
    Parihar, Ashwin S.
    Bhattacharya, Anish
    Basher, Rajender K.
    Kapoor, Rakesh
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (01) : 63 - 72
  • [23] Predicting EGFR mutation subtypes in lung adenocarcinoma using 18F-FDG PET/CT radiomic features
    Liu, Qiufang
    Sun, Dazhen
    Li, Nan
    Kim, Jinman
    Feng, Dagan
    Huang, Gang
    Wang, Lisheng
    Song, Shaoli
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 549 - +
  • [24] Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on 18F-FDG PET/CT for Patients with Colorectal Cancer
    Liu, Xin
    Xiang, Kun
    Geng, Guang-Yong
    Wang, Shi-Cun
    Ni, Ming
    Zhang, Yi-Fan
    Pan, Hai-Feng
    Lv, Wei-Fu
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [25] Validity of 18F-FDG PET/CT Scan for Detection of Metastatic Lesion of Pancreatic Adenocarcinoma in Diabetic Patients
    Paik, Kyu-hyun
    Hwang, Jin-Hyeok
    Kim, Hyoung Woo
    Lee, Jong-chan
    Lee, Yoon Suk
    Kim, Jaihwan
    GASTROENTEROLOGY, 2015, 148 (04) : S394 - S395
  • [26] Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate
    Molina-Garcia, David
    Maria Garcia-Vicente, Ana
    Perez-Beteta, Julian
    Amo-Salas, Mariano
    Martinez-Gonzalez, Alicia
    Jesus Tello-Galan, Maria
    Soriano-Castrejon, Angel
    Perez-Garcia, Victor M.
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (06) : 379 - 388
  • [27] Prognostic Value of Volume-Based Metabolic Parameters Measured by 18F-FDG PET/CT of Pancreatic Neuroendocrine Tumors
    Kim H.S.
    Choi J.Y.
    Choi D.W.
    Lim H.Y.
    Lee J.H.
    Hong S.P.
    Cho Y.S.
    Lee K.-H.
    Kim B.-T.
    Nuclear Medicine and Molecular Imaging, 2014, 48 (3) : 180 - 186
  • [28] Diagnosis and prognostic predictive value of delineation methods from 18F-FDG PET/CT and PET/MR in pancreatic lesion
    Hu, Fan
    Zhang, Xiao
    Shu, Hua
    Wang, Xiaoli
    Feng, Shuqian
    Hu, Mengmeng
    Lan, Xiaoli
    Qin, Chunxia
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 13 (06): : 269 - 278
  • [29] 18F-FDG uptake of visceral adipose tissue on preoperative PET/CT as a predictive marker for breast cancer recurrence
    Paik, Pill Sun
    Yoon, Chang Ik
    Kim, Hyun Jeong
    Cha, Yoon Jin
    Kim, Dooreh
    Bae, Soong June
    Ahn, Sung Gwe
    Jeong, Joon
    Park, Woo-Chan
    Ryu, Young Hoon
    Jeon, Tae Joo
    Kim, Chai Won
    CANCER RESEARCH, 2022, 82 (04)
  • [30] Prognostic value of metabolic tumor volume and total lesion glycolysis assessed by 18F-FDG PET/CT in endometrial cancer
    Erdogan, Mehmet
    Erdemoglu, Evrim
    Evrimler, Sehnaz
    Hanedan, Candost
    Sengul, Sevim S.
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (11) : 1099 - 1104
12345